menu
    • menu

    Company profile for Faron Pharmaceuticals

    NEW Drugs in Dev: 3
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that, due to the prevailing Covid-19 situation, the Company's Board of Directors has decided to cancel the Company's annual general meeting ("AGM") scheduled to be held on 15 April 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Faron PharmaceuticalsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Joukahaisenkatu 6 FI-20520 TURKU
    Telephone
    Telephone
    +358 2 469 5151
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.faron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Faron Pharmaceuticals Ltd: Holdings in Company
    Faron Pharmaceuticals Ltd: Holdings in Company

    11 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-holdings-in-company-1176019

    ACCESSWIRE
    11 Jun 2026
    Share Share
    Faron Pharmaceuticals Ltd: Registration of Treasury Shares
    Faron Pharmaceuticals Ltd: Registration of Treasury Shares

    11 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-registration-of-treasury-shares-1176018

    ACCESSWIRE
    11 Jun 2026
    Share Share
    Faron Pharmaceuticals Ltd: Holding(s) in Company
    Faron Pharmaceuticals Ltd: Holding(s) in Company

    10 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-holdings-in-company-1175051

    ACCESSWIRE
    10 Jun 2026
    Share Share
    Faron Pharmaceuticals LTD: Holding(s) in Company
    Faron Pharmaceuticals LTD: Holding(s) in Company

    08 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-holdings-in-company-1173981

    ACCESSWIRE
    08 Jun 2026
    Share Share
    Faron Pharma Receives Nasdaq Helsinki Disciplinary Decision
    Faron Pharma Receives Nasdaq Helsinki Disciplinary Decision

    05 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-receives-decision-from-nasdaq-helsinki-disciplinary-committee-1173647

    ACCESSWIRE
    05 Jun 2026
    Share Share
    Faron Pharmaceuticals: Holdings in Company Disclosed
    Faron Pharmaceuticals: Holdings in Company Disclosed

    04 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-holdings-in-company-1173326

    ACCESSWIRE
    04 Jun 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search